Journal of the Neurological Sciences
Volume 311, Supplement 1 , Pages S29-S34, December 2011

Balancing the benefits and risks of disease-modifying therapy in patients with multiple sclerosis

  • Per Soelberg Sørensen

      Affiliations

    • Corresponding Author InformationCorrespondence: Prof. Per Soelberg Sorensen, MD, DMSci, Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital Rigshospitalet, DK-2100 Copenhagen, Denmark

Danish Multiple Sclerosis Research Centre, Copenhagen University and Rigshospitalet, Copenhagen, Denmark

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0022-510X(11)70006-5

doi:10.1016/S0022-510X(11)70006-5

Journal of the Neurological Sciences
Volume 311, Supplement 1 , Pages S29-S34, December 2011

Article Tools